Pro Dex PDEX
NASDAQ PDEX
$65.67 -0.64 (-0.97%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pro Dex (PDEX) Net Income towards Common Stockholders (2010 - 2026)

Pro Dex (PDEX) posted Net Income towards Common Stockholders of $3.9 million for Q1 2026, up 80.06% sequentially from $2.2 million in Q4 2025, and up 20.24% YoY from $3.3 million in Q1 2025.

Pro Dex (PDEX) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Pro Dex has reported Net Income towards Common Stockholders for 14 years, with the latest figure at $3.9 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders rose 20.24% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.0 million (up 28.12% YoY) and the FY2025 annual result came in at $9.0 million, up 322.1% from the prior year.
  • Net Income towards Common Stockholders climbed to $3.9 million in Q1 2026 per PDEX's latest filing, from $2.2 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $4.7 million in Q3 2025 and troughed at -$615000.0 in Q3 2023.
  • A 5-year average of $1.9 million and a median of $2.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • The sharpest annual moves came in 2023 and 2024: Net Income towards Common Stockholders slumped 151.12% in 2023, then jumped 500.98% in 2024.
  • Over 5 years, Net Income towards Common Stockholders stood at $2.8 million in 2022, then tumbled by 81.83% to $500000.0 in 2023, then jumped by 308.0% to $2.0 million in 2024, then rose by 7.21% to $2.2 million in 2025, then soared by 80.06% to $3.9 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $3.9 million, $2.2 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 378.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 383.43 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 139.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 147.90 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 93.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -77.90 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 126.00 Mn
10 Pro Dex 209.47 Mn 198.49 Mn 6.13 Mn 3.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.94 Mn
Dec 31, 2025 2.19 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 3.28 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 2.47 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 655,000.00
Dec 31, 2023 500,000.00
Sep 30, 2023 -615,000.00
Jun 30, 2023 2.11 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 2.75 Mn
Sep 30, 2022 1.20 Mn
Jun 30, 2022 2.51 Mn
Mar 31, 2022 462,000.00
Dec 31, 2021 925,000.00
Sep 30, 2021 1.37 Mn
Jun 30, 2021 1.10 Mn